Inspire Medical Systems (INSP) Change in Account Payables (2017 - 2026)
Inspire Medical Systems (INSP) reported Change in Account Payables of $7.1 million for Q1 2026, up 174.94% on a YoY basis from $2.6 million in Q1 2025, and up 132.27% sequentially from -$22.1 million in Q4 2025.
Inspire Medical Systems (INSP) Change in Account Payables (2017 - 2026) Analysis & Trends
Inspire Medical Systems (INSP) has 10 years of Change in Account Payables data on file, last reported at $7.1 million in Q1 2026.
- For the quarter ending Q1 2026, Change in Account Payables rose 174.94% year-over-year to $7.1 million; the trailing twelve-month figure through Mar 2026 stood at $12.9 million (up 203.46% YoY), and the FY2025 full-year result was -$3.7 million, down 720.36% from the prior year.
- Change in Account Payables climbed to $7.1 million in Q1 2026, from -$22.1 million in the prior quarter.
- In the past five years, Change in Account Payables ranged from a high of $21.3 million in Q2 2025 to a low of -$22.1 million in Q4 2025.
- A 5-year average of $1.6 million and a median of $3.6 million in 2024 frame the typical range for Change in Account Payables.
- Peak annual rise in Change in Account Payables reached 349.16% in 2025, while the deepest fall reached 657.89% in 2025.
- Tracing INSP's Change in Account Payables over 5 years: stood at $5.8 million in 2022, then slumped by 130.92% to -$1.8 million in 2023, then jumped by 322.65% to $4.0 million in 2024, then tumbled by 657.89% to -$22.1 million in 2025, then jumped by 132.27% to $7.1 million in 2026.
- Business Quant data shows INSP's Change in Account Payables at $7.1 million in Q1 2026, -$22.1 million in Q4 2025, and $6.5 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -198.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | - |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 221.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Inspire Medical Systems | 1.46 Bn | 1.17 Bn | 176.91 Mn | 7.13 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7.13 Mn |
| Mar 31, 2026 | 7.13 Mn |
| Dec 31, 2025 | -22.10 Mn |
| Dec 31, 2025 | -22.10 Mn |
| Sep 30, 2025 | 6.54 Mn |
| Sep 30, 2025 | 6.54 Mn |
| Jun 30, 2025 | 21.33 Mn |
| Jun 30, 2025 | 21.33 Mn |
| Mar 31, 2025 | -9.52 Mn |
| Mar 31, 2025 | -9.52 Mn |
| Dec 31, 2024 | 3.96 Mn |
| Dec 31, 2024 | 3.96 Mn |
| Sep 30, 2024 | 1.65 Mn |
| Sep 30, 2024 | 1.65 Mn |
| Jun 30, 2024 | -8.56 Mn |
| Jun 30, 2024 | -8.56 Mn |
| Mar 31, 2024 | 3.56 Mn |
| Mar 31, 2024 | 3.56 Mn |
| Dec 31, 2023 | -1.78 Mn |
| Dec 31, 2023 | -1.78 Mn |